NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 39 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,094,554 | $2,568,480 | 1.68% |
| Western Standard LLC | 860,882 | $714,532 | 0.62% |
| Redmile Group, LLC | 2,912,228 | $2,417,149 | 0.09% |
| Privium Fund Management (UK) Ltd | 117,200 | $94,932 | 0.08% |
| Alta Fundamental Advisers LLC | 89,702 | $74,453 | 0.04% |
| Privium Fund Management B.V. | 117,200 | $94,932 | 0.02% |
| Baker Brothers Advisors | 3,821,740 | $3,172,044 | 0.02% |
| BML Capital Management, LLC | 23,749 | $19,712 | 0.02% |
| Kynam Capital Management, LP | 119,966 | $99,572 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 23,428 | $19,445 | 0.00% |
| Renaissance Technologies | 937,223 | $778 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,200 | $11,786 | 0.00% |
| HighTower Advisors, LLC | 48,409 | $40,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 184,500 | $153,135 | 0.00% |
| Truvestments Capital LLC | 925 | $768 | 0.00% |
| JPMORGAN CHASE & CO | 223 | $185 | 0.00% |
| Farther Finance Advisors, LLC | 1,000 | $830 | 0.00% |
| BARCLAYS PLC | 163 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 592 | $0 | 0.00% |
| VANGUARD GROUP INC | 1,010,812 | $838,974 | 0.00% |
External links
This page lists NEOLEUKIN THERAPEUTICS INC's shareholders in Q2 2023. To view NEOLEUKIN THERAPEUTICS INC's shareholder history, click here.